This is an important issue for our transplant patients, but I believe important for nephrologists also. It makes no sense that some patients who can't afford their medications return to the transplant list because their allograft fails. The waiting is already long and it will only get longer.
Besides, the most important reason is that returning patients to dialysis makes no human or financial sense. Look at the data: the renal transplant outcomes in our patients in the US are worse than other comparable countries that provide coverage. The data that Gill and Tonelli cite in their perspective article is pause for thought.
I know it takes time to complete a petition, but please take the time.
Here is the link.
 |
| Source: Gill and Tonelli, NEJM, 2012 |
Organizations that support the legislation:
American
Transplant Foundation
National
Kidney Foundation (NKF)
American
Society of Transplantation (AST)
American
Society of Transplant Surgeons (ASTS)
United
Network for Organ Sharing (UNOS)
American
Society of Nephrology (ASN)
American
Society of Pediatric Nephrology (ASPN)
Association
of Organ Procurement Organizations (AOPO)
Renal
Physicians Association (RPA)
American
Association of Tissue Banks (AATB)
Polycystic
Kidney Disease – PKD Foundation (PKD)
Transplant
Recipients International Organization (TRIO)
Renal
Support Network (RSN)
American
Association for the Study of Liver Diseases (AASLD)
NATCO,
The Organization for Transplant Professionals
Texas
Transplantation Society
Juvenile
Diabetes Research Foundation (JDRF)
Eye
Bank Association of America (EBAA)
Dialysis
Patient Citizens (DPC)
American
Association of Kidney Patients (AAKP)
